Abstract RTS. S/AS01 is an advanced pre-erythrocytic malaria vaccine candidate with demonstrated vaccine efficacy up to 86. 7% in controlled human malaria infection (CHMI) studies; however. reproducible immune correlates of protection (CoP) are elusive. https://www.opheliasmuse.com/